MATTHEW CARTER: Open Payments
NPI 1073226338 · BOILING SPRINGS, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 42 payments from 13 companies in 2025. Trend: 2023 $594 · 2024 $1,083 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $169 |
| PFIZER INC. | 8 | $160 |
| Novo Nordisk Inc | 5 | $79 |
| Lilly USA, LLC | 4 | $71 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Corium, LLC | 1 | $28 |
| Verona Pharma, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $16 |
| Medtronic, Inc. | 1 | $16 |
| SANOFI-AVENTIS U.S. LLC | 1 | $15 |
Products named: VRAYLAR, NURTEC ODT, ELIQUIS, MOUNJARO, Ozempic, QULIPTA, FARXIGA, Rybelsus.
Industry payments across SC — which companies pay providers there.
